Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Masaya HattoriNaoko HonmaYutaka Yamamoto Special Article Open access 04 March 2024 Pages: 335 - 339
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Yutaka YamamotoChikako YamauchiShigehira Saji Special Article Open access 03 April 2024 Pages: 340 - 346
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition Michio YoshimuraChikako YamauchiShigehira Saji Special Article Open access 05 April 2024 Pages: 347 - 357
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer Xue Hu Review Article 14 March 2024 Pages: 358 - 370
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models Hongyan ZhengLihua WuGe Lou Original Article 30 January 2024 Pages: 371 - 381
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer Kazuhiko SatoHiromi FuchikamiMasahiro Kato Original Article 15 February 2024 Pages: 382 - 390
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Nalee KimWon Kyung ChoHaeyoung Kim Original Article 18 February 2024 Pages: 391 - 400
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Yasue TsuchidaNaoki NiikuraNaoki Hayashi Original Article 07 March 2024 Pages: 401 - 408
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Kumiko KidaAkimitsu YamadaTakashi Ishikawa Original Article 08 March 2024 Pages: 409 - 416
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer Jin-hui YeJian YuYue-mei Mo Original Article Open access 01 April 2024 Pages: 417 - 425
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB Guo LiXinyue LinZhichao Fu Original Article 12 March 2024 Pages: 426 - 439
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β Monalisa ParijaSurya PrakashSandip K. Mishra Original Article 29 February 2024 Pages: 440 - 455
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap Joep A. F. van RooijEnnie BijkerkStefania M. H. Tuinder Original Article Open access 06 April 2024 Pages: 456 - 466
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Danbee KangSeri ParkYeon Hee Park Original Article 12 March 2024 Pages: 467 - 475
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer Kazutaka NaruiToshihiko SatakeItaru Endo Original Article 21 March 2024 Pages: 476 - 484
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer Kim VoColton LadburyArya Amini Original Article Open access 20 March 2024 Pages: 485 - 495
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020 Ewe Seng Ch’ng Original Article 28 March 2024 Pages: 496 - 506
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy Hiroko NogiAkiko OgiyaThe Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society Original Article Open access 04 April 2024 Pages: 507 - 518
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy Dan LinKathleen M. SturgeonCheryl L. Thompson Original Article 02 April 2024 Pages: 519 - 528
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer Sean M. HackingGabrielle WindsorYihong Wang Rapid Communication 13 February 2024 Pages: 529 - 535
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Reiko FukuiTakahiro WatanabeYasuo Miyoshi Letter to the Editor 04 March 2024 Pages: 536 - 538